Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorysemaxfdarfk-jrgray-market

Trump administration weighs easing rules on unapproved peptides

Washington Post reports a possible temporary relaxation while new regulations are drafted, as Bloomberg describes a billion-dollar gray market for research peptides.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 9 05:25 ETSource: ThePrint

The wire

  1. 01The Washington Post reported the administration is considering temporarily relaxing restrictions on certain unapproved peptides, with no formal announcement yet; HHS Secretary Robert F. Kennedy Jr. is described as a supporter.
  2. 02Bloomberg put the gray market in the billions, citing a Reddit peptide group with over 174,000 members and a seller-matching platform with roughly 87,000 members and 257,000 posts.
  3. 03Compounds such as Semax remain unapproved in the US with little evidence of efficacy or long-term safety; a planned 'peptide party' in Bengaluru was shut down by Karnataka drug regulators.

From the source

Do peptides really boost brainpower? They’re the new kings of DIY medicine

New Delhi: Peptides are all the rage among Americans looking to ‘hack’ their brains, get a competitive edge and even slow down ageing. US Health Secretary Robert F. Kennedy Jr. is a “ big fan ”, and now the Trump administration is reportedly considering letting pharmacies sell some unapproved peptides.

Read at theprint.in
PeptiPrescribed peptides from $99/moSee all →